Fundamentals will win, and shareholders will benefit from energy companies generating "asinine amounts" of free cash flow, says energy analysts at HFI Research.
HFI is a contrarian investment research firm whose current focus is on the energy and natural gas markets.
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.
Cidara Therapeutics, Inc. (NASDAQ: CDTX) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead asset Rrezafungin for the treatment of candidemia and invasive candidiasis.
Who are the most experienced and engaged cannabis finance reports? Let's find out.
After the overwhelming success of Benzinga's 4/20 Miami event, the Benzinga Cannabis Capital Conference is returning to Chicago on September 13-14.